Travel Time to Treating Center is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel Disease
McLaughlin, Joi F; Linville, Tiffany; Jester, Traci W; Marciano, Tuvia A; Lazare, Farrah; Dotson, Jennifer L; Samson, Charles; Niklinska-Schirtz, Barbara; Cabrera, Jose; Leibowtiz, Ian; Batra, Suruchi; Ammoury, Rana; Strople, Jennifer A; Saeed, Shehzad; Sandberg, Kelly C; Tung, Jeanne; Verstraete, Sofia G; Cox, Ryan F; Na, Sera; Steiner, Steven J; Ali, Sabina A; Israel, Esther J; Dorsey, Jill; Adler, Jeremy; Rekhtman, Yuliya; Egberg, Matthew D; Waduge, Emmala Ryan; Savas, Jen; Brensinger, Colleen M; Lewis, James D; Kappelman, Michael D
BACKGROUND & AIMS/OBJECTIVE:Delayed diagnosis of inflammatory bowel disease (IBD) leads to prolonged symptoms and worse long-term outcomes. We sought to evaluate whether race, ethnicity, disease type, and social factors are associated with delayed diagnosis of pediatric IBD. METHODS:We performed a cross-sectional study of newly diagnosed pediatric patients with IBD at 22 United States sites from 2019 to 2022. Parents/guardians reported race, ethnicity, time between symptom onset and diagnosis, and other social determinants of health. Through bivariate and multivariable analyses using generalized estimating equations, we evaluated associations between these factors and diagnosis time defined as ≤60 days, 61 to 180 days, 181 to 365 days, and >365 days. RESULTS:We enrolled 869 participants (mean age at diagnosis, 13.1 years; 52% male; 57% Crohn's disease [CD]; 34% ulcerative colitis [UC]; 8% Hispanic; 30% non-White). Overall, the mean time to diagnosis was 265.9 days. After adjustment, factors associated with longer diagnosis time included CD vs UC (odds ratio [OR], 2.6; 95% confidence interval [CI], 1.9-3.5), 2 or more other health conditions (OR, 1.7; 95% CI, 1.1-2.7), and longer travel time to clinic (>1 hour [OR, 1.7; 95% CI, 1.2-2.4], >2 hours (OR, 1.8; 95% CI, 1.2-2.9] each vs <30 minutes). There was no association with race, ethnicity, birth country, sex, parent education, household income, insurance type, health literacy, and health system distrust. CONCLUSIONS:Consistent with prior literature, diagnostic delay is longer for CD than UC. Reassuringly, time to diagnosis is equitable across racioethnic groups. New models of diagnostic care are needed for communities affected by longer travel times.
PMID: 39181423
ISSN: 1542-7714
CID: 5729412
Type 2 autoimmune pancreatitis: case report of a 9-year-old female and a review of the literature [Case Report]
Patel, Zinal; Patel, Suril; Grendell, James; Marciano, Tuvia
We report a case of autoimmune pancreatitis in a 9-year-old female who presented with persistent epigastric pain for 3 weeks. Magnetic resonance cholangiopancreatography (MRCP) showed both intrahepatic and extrahepatic biliary ductal dilatation. The common bile duct, along with the pancreatic duct, was noted to be dilated. Labs showed normal IgG and IgG4 levels and negative for autoimmune antibodies. Endoscopic ultrasound revealed the pancreatic head to be enlarged and surrounded by hypoechoic and lobulated lymph nodes. Biopsy of the pancreatic head showed chronic mildly active inflammation with fibrosis, acinar atrophy, and lymphocytic infiltrate. A diagnosis of autoimmune pancreatitis (AIP) was made, and she was treated with prednisone. The patient's symptoms improved quickly, and follow-up MRCP showed resolution of inflammatory changes and intrahepatic and pancreatic ductal dilatation.
PMID: 26590828
ISSN: 1865-7265
CID: 3411982
Low-dose acyclovir for HSV-2 meningitis in a child [Case Report]
Kohlhoff, S A; Marciano, T A; Rawstron, S A
A 7-y-old girl with genital herpes following sexual abuse presented with dysuria, fever and meningeal signs. Acyclovir (15 mg/kg/d for 10 d) was administered for severe genitourinary symptoms. The CSF culture was positive for HSV type 2. Complete resolution of all symptoms demonstrates that, as in adults, HSV-2 meningitis does not require high-dose or prolonged acyclovir therapy.
PMID: 15456207
ISSN: 0803-5253
CID: 3537892